" /> Mosunetuzumab/Polatuzumab Vedotin Regimen - CISMeF





Preferred Label : Mosunetuzumab/Polatuzumab Vedotin Regimen;

NCIt synonyms : Mosunetuzumab Plus Polatuzumab Vedotin-piiq; Mosunetuzumab-axgb/Polatuzumab Vedotin-piiq; Polivy/Lunsumio; Mosunetuzumab Plus Polatuzumab Vedotin; Lunsumio/Polivy Regimen; Mosunetuzumab/Polatuzumab Vedotin; Polatuzumab Vedotin/Mosunetuzumab; Polatuzumab Vedotin-piiq/Mosunetuzumab-axgb; Mosunetuzumab-Polatuzumab Vedotin;

NCIt definition : A regimen consisting of mosunetuzumab and polatuzumab vedotin that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL).;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.